Pulmonx Q3 EPS $(0.19) Beats $(0.26) Estimate, Sales $22.835M Beat $21.944M Estimate
Benzinga Newsdesk 4 days ago
NewsEarningsEarnings Beats
Pulmonx (NASDAQ:LUNG) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.26) by 26.92 percent. This is a 44.12 percent increase over losses of $(0.34) per share from the same
Pulmonx (NASDAQ:LUNG) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.26) by 26.92 percent. This is a 44.12 percent increase over losses of $(0.34) per share from the same period last year. The company reported quarterly sales of $22.835 million which beat the analyst consensus estimate of $21.944 million by 4.06 percent. This is a 6.20 percent increase over sales of $21.502 million the same period last year.